# Sihuan Pharmaceutical Holdings Group Ltd. trials: 23 (2026)

ClinicalTrials.gov lists 23 trials with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Sihuan Pharmaceutical Holdings Group Ltd.: 23 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/sihuan-pharmaceutical-holdings-group-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2020 | NCT04622072 | XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Terminated | Non Small Cell Lung Cancer | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04622072) |
| September 7, 2020 | NCT04539496 | A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1/2 | Unknown | Metastasis Solid Tumors, Advanced Breast Cancer | 402 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04539496) |
| August 10, 2020 | NCT04505683 | A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute... | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 2/3 | Completed | Complicated Urinary Tract Infection Including Acute Pyelonephritis | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04505683) |
| August 7, 2020 | NCT04503629 | A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 2 | Completed | Duodenal Ulcer，DU | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04503629) |
| July 20, 2020 | NCT04476407 | Pharmacokinetics of Benapenem in Subjects With Renal Impairment | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Complicated Urinary Tract Infection; Cuti | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04476407) |
| July 20, 2020 | NCT04476394 | Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of \[14C\]-20 mg/100 μCi Anaprazole... | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Unknown | Healthy Male Volunteers | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04476394) |
| July 15, 2020 | NCT04471922 | A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Volunteers | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04471922) |
| July 10, 2020 | NCT04467203 | Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04467203) |
| July 10, 2020 | NCT04467060 | A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Male Volunteers | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04467060) |
| July 10, 2020 | NCT04466748 | A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Volunteers | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04466748) |
| July 9, 2020 | NCT04463173 | Food Effect Study of Anaprazole in Healthy Chinese Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Male Volunteers | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04463173) |
| June 23, 2020 | NCT04444011 | Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Unknown | Healthy Male Volunteers | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04444011) |
| March 18, 2020 | NCT04312568 | Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Subject | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04312568) |
| January 2, 2020 | NCT04215653 | A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 3 | Unknown | Duodenal Ulcer，DU | 448 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04215653) |
| December 16, 2019 | NCT04200261 | Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Unknown | Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04200261) |
| February 22, 2019 | NCT03851432 | Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 3 | Unknown | Diabetes Mellitus, Type 2 | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03851432) |
| January 22, 2019 | NCT03811548 | Janagliflozin Treat T2DM Monotherapy | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 3 | Unknown | Diabetes Type 2 | 442 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03811548) |
| July 17, 2018 | NCT03588156 | Single-dose PK Study of Benapenem In Healthy Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Subject | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03588156) |
| July 6, 2018 | NCT03578588 | Benapenem PK Phase Ib Multiple-dose Study | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Health, Subjective | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03578588) |
| June 27, 2018 | NCT03570970 | Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Healthy Subject | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03570970) |
| May 13, 2015 | NCT02442414 | A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 1 | Completed | Advanced Solid Tumors | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02442414) |
| November 24, 2014 | NCT02299804 | A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 2 | Completed | Vertigo | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02299804) |
| September 16, 2014 | NCT02241629 | Levo Phencynonate Hydrochloride for the Prevention of Seasickness | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 2 | Completed | Motion Sickness | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02241629) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 15 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 15 |
| Unknown | 7 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Vertigo | 1 |
| Neoplasms | 1 |
| Stomach Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Motion Sickness | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Hyperbaric medicine centers in the United States](https://specstream.ai/data/businesses/hyperbaric-medicine-centers/united-states)
- [Stone suppliers in the United States](https://specstream.ai/data/businesses/stone-suppliers/united-states)
- [Cosmetology schools in the United States](https://specstream.ai/data/businesses/cosmetology-schools/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [Aggregate suppliers in the United States](https://specstream.ai/data/businesses/aggregate-suppliers/united-states)
